NuVasive, Inc.
NUVA
NUVA was delisted on the 31st of August, 2023.
257 hedge funds and large institutions have $3.14B invested in NuVasive, Inc. in 2016 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 97 increasing their positions, 81 reducing their positions, and 36 closing their positions.
82% more call options, than puts
Call options by funds: $5.4M | Put options by funds: $2.96M
31% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 36
27% more capital invested
Capital invested by funds: $2.48B → $3.14B (+$668M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
20% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 81
3% more funds holding
Funds holding: 249 → 257 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$63.5M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$33.8M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$27.1M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$22.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$22.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$67M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$45.4M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$40.5M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$23.4M |
| 5 |
HCM
Hodges Capital Management
Dallas,
Texas
|
-$19.5M |
NUVA Hedge Fund Activity: Q2 2016 in Review
257 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q2 2016, worth a combined $3.14B — up 27% from $2.48B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new NUVA positions and 36 closed out — a net gain of 11 holders — while 97 added to existing stakes and 81 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $63.5M. The largest seller was OrbiMed, cutting an estimated $67M.
- 257 institutional investors held NuVasive, Inc. (NUVA) as of Q2 2016, up from 249 in Q1 2016.
- Funds reported $3.14B of NuVasive, Inc. stock for Q2 2016, up 27% quarter-over-quarter.
- 47 funds opened new NuVasive, Inc. positions in Q2 2016 and 36 closed out, a net change of +11 holders.
- The largest NuVasive, Inc. buyer in Q2 2016 was Goldman Sachs, an estimated $63.5M added.
- The largest NuVasive, Inc. seller in Q2 2016 was OrbiMed, an estimated $67M sold.
Based on aggregated 13F filings for Q2 2016.